Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:25 am Sale | 13G | Quanterix Corp QTRX | Camber Capital Management LP | 0 0.000% | -3,425,000 (Position Closed) | View |
| 2024-02-14 08:24 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 7,635,000 8.500% | 635,000 (+9.07%) | View |
| 2024-02-14 08:23 am Purchase | 13G | INOGEN INC INGN | Camber Capital Management LP | 2,000,000 8.580% | 400,000 (+25.00%) | View |
| 2024-02-14 08:22 am Purchase | 13G | ZIMVIE INC ZIMV | Camber Capital Management LP | 3,250,000 12.250% | 650,000 (+25.00%) | View |
| 2024-02-14 08:21 am Purchase | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 18,733,525 9.780% | 733,525 (+4.08%) | View |
| 2024-02-14 08:19 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,805,000 5.900% | -1,430,000 (-33.77%) | View |
| 2023-10-30 09:05 am Purchase | 13G | PTC THERAPEUTICS INC PTCT | Camber Capital Management LP | 4,000,000 5.310% | 4,000,000 (New Position) | View |
| 2023-07-24 09:50 am Purchase | 13G | INOGEN INC INGN | Camber Capital Management LP | 1,600,000 6.920% | 1,600,000 (New Position) | View |
| 2023-02-14 08:46 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 7,000,000 8.640% | 2,300,000 (+48.94%) | View |
| 2023-02-14 08:40 am Purchase | 13G | Quanterix Corp QTRX | Camber Capital Management LP | 3,425,000 9.240% | 425,000 (+14.17%) | View |
| 2023-02-14 08:36 am Purchase | 13G | ZIMVIE INC ZIMV | Camber Capital Management LP | 2,600,000 9.970% | 600,000 (+30.00%) | View |
| 2023-02-14 08:33 am Purchase | 13G | Brookdale Senior Living Inc. BKD | Camber Capital Management LP | 18,000,000 9.640% | 2,000,000 (+12.50%) | View |
| 2023-02-14 08:30 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 4,235,000 9.280% | 2,185,000 (+106.59%) | View |
| 2023-02-02 2:53 pm Unchanged | 13G | ORASURE TECHNOLOGIES INC OSUR | Camber Capital Management LP | 4,250,000 5.850% | 0 (Unchanged) | View |
| 2022-12-12 09:50 am Purchase | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LP | 1,418,440 7.260% | 1,418,440 (New Position) | View |
| 2022-08-19 4:02 pm Purchase | 13G | Quanterix Corp QTRX | Camber Capital Management LP | 3,000,000 8.110% | 3,000,000 (New Position) | View |
| 2022-05-12 4:06 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 4,700,000 5.850% | 1,950,000 (+70.91%) | View |
| 2022-03-21 09:11 am Purchase | 13G | ZIMVIE INC ZIMV | Camber Capital Management LP | 2,000,000 7.680% | 2,000,000 (New Position) | View |
| 2022-02-14 09:40 am Sale | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Camber Capital Management LP | 1,050,000 3.040% | -950,000 (-47.50%) | View |
| 2022-02-14 09:39 am Sale | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 2,750,000 3.440% | -2,250,000 (-45.00%) | View |